Croup Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
Croup Treatment Market: Introduction
- Croup is a medical condition that refers to an infection of the upper airway, which further disrupts breathing, thereby resulting into barking cough. Croup typically occurs in children and is often treatable at home. Symptoms of croup include swelling around the larynx (voice box), windpipe, and bronchi. The cough forcible tries to move through the passageway and swollen vocal cords, which results into a seal-like barking noise. Other symptoms include fever, hoarse voice, and noisy breathing. The croup condition lasts for three to five days normally. Children between the ages of 6 months and 3 years are at higher risk of getting croup, as children have small airways, and they are most susceptible to acquire the symptoms.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77740
- Croup is commonly caused by parainfluenza virus and is easier to contract through droplets in the air. Sanitization and continuous hand washing are few preventive measures against croup. As per NCBI research published in April 2020, in the U.S., annually croup accounts for 7% of hospitalizations in children below 5 years of age. Laryngotracheitis, laryngotracheobronchitis, and laryngotracheobronchopneumonitis are covered under the croup spectrum. Croup is a highly common respiratory illness caused most commonly by viruses and a few by bacteria too. Parainfluenza virus caused primarily type 1 and type 2 viral croup, and other viruses’ causes’ adenovirus, influenza A and B, measles, and respiratory syncytial virus. The bacteria caused laryngeal diphtheria, laryngotracheobronchitis, bacterial tracheitis, and laryngotracheobronchopneumonitis croup.
Key Drivers and Restraints of Global Croup Treatment Market
- Rise in prevalence of croup diseases, especially in children between the ages of 6 months and 3 years is projected to drive the global croup treatment market. According to NCBI data published in April 2020, croup affects around 3% of children every year, globally. Moreover, parainfluenza virus accounted for 75% of croup infections in children. Majority of cases reported were estimated to be higher in males than females, and approx., 85% of croup cases registered were mild croup. This is likely to boost the need for treatment of croup condition. Furthermore, around 15% of respiratory infections in children was caused due to croup.
- Availability of generic medication and other treatment, including oxygen therapies and intubation, is estimated to offer treatment for croup. Additionally, awareness related to croup and guidelines related to the treatment of croup is estimated to propel the croup treatment market globally.
Request for Analysis of COVID19 Impact on Croup Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77740
North America to Lead Global Croup Treatment Market
- In terms of region, the global croup treatment Market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is projected to dominate the global croup treatment market during the forecast period due to an increase in prevalence of croup disease especially in children across the region. As per NBCI research in April 2020, croup is likely to affect around 3% of children every year in the U.S. Moreover, in the U.S., croup accounted for 15% emergency department visits. Moreover, rising respiratory conditions in the U.S. is anticipated to propel the market of croup treatment in the region Availability of generic medicines such as corticosteroids, epinephrine, and other medicines for treatment of croup condition would boost the market in the region.
- Europe was the second-largest market for croup treatment followed by Asia Pacific, owing to the rising prevalence of condition in winters, and especially among children in the region. As per Royal College of Emergency Medicine’s, in the U.K., 80% of children with symptoms of acute onset of stridor and cough are likely to have croup. Furthermore, croup is estimated to occur in 2% of children between the ages of 6 months and 36 months in the U.K. Moreover, male to female ratio of acquiring croup is 3:2.
Pre Book Croup Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77740<ype=S
Key Players Operating in Global Croup Treatment Market
The global croup treatment market is fragmented, owing to the presence many large- and small-sized players. Major players operating in the global croup treatment market are:
- Mylan N.V
- Ethypharm Group Company
- Rosemont Pharmaceuticals Ltd,
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Smiths Medical
- Boehringer Ingelheim International GmbH
- Hikma Pharmaceuticals
- Sanofi
Global Croup Treatment Market: Research Scope
Global Croup Treatment Market, by Disease Type
- Viral Croup
- Bacteria Croup
- Laryngeal diphtheria
- Bacterial tracheitis
- Laryngotracheobronchitis
- Laryngotracheobronchopneumonitis
Global Croup Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
The new report by Expert Market Research titled, ‘Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global ABSSSI market, assessing the market based on its segments like infection type, route of administration, distribution channel, and major regions like Asia Pacific, Europe, North America, Middle East and Africa and Latin America.
The sample report shall be delivered to you within 24 hours.Request a free sample copy in PDF or view the report summary@https://www.expertmarketresearch.com/reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market/requestsampleThe key highlights of the report include:Market Overview (2021-2026)Historical Market Size (2020): USD 9.3 BillionForecast CAGR (2021-2026): 7%Forecast Market Size (2026): USD 14 BillionThe growth of global ABSSSI is driven by the rising prevalence of skin infections.
Additionally, the developing antibiotic resistance in pathogenic bacteria, and mutations resulting in the newer strains is expected to drive the demand for the ABSSI Market.
Further the government spending on healthcare and infrastructure will propel the market in the forecast period.Industry Definition and Major SegmentsABSSSI are mild or severe forms infections caused by pathogens like streptococcus pyogenes and Staphylococcus aureus.
These drugs are pathogen specific and may require surgical excision of lesion in extreme cases.Explore the full report with the table of contents@https://www.expertmarketresearch.com/reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-marketThe acute bacterial skin and skin structure infections (ABSSSI) treatment industry can be segmented by infection type:Hospital-acquired ABSSSICommunity-acquired ABSSSIOthersIt may be differentiated on the basis of route of administration:OralParenteralThe industry may be classified on the basis of distribution channel:Hospital PharmacyRetail PharmacyOnlineOthersLatest Global News on Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market@https://www.expertmarketresearch.com/pressrelease/global-absssi-treatment-marketOn the basis of regional markets, the industry is divided into:1 North America1.1 United States of America1.2 Canada2 Europe2.1 Germany2.2 United Kingdom2.3 France2.4 Italy2.5 Others3 Asia Pacific3.1 China3.2 Japan3.3 India3.4 ASEAN3.5 Others4 Latin America4.1 Brazil4.2 Argentina4.3 Mexico4.4 Others5 Middle East & Africa5.1 Saudi Arabia5.2 United Arab Emirates5.3 Nigeria5.4 South Africa5.5 OthersMarket TrendsRegionally, North America is the largest shareholder in the global ABSSSI market, due to the presence of a robust healthcare system.
This can be attributed to the rapidly advancing healthcare sector, increasing population, and growing awareness about various skin aliments.Key Market PlayersThe major players in the market are Debiopharm International SA, Melinta Therapeutics, Inc., Paratek Pharmaceuticals, Inc., GlaxoSmithKline plc, and a few others.
Hydrogen-Terminated Silicone Fluid Market research report includes specific segments by region (country), by manufacturers, by Type and by Application.
Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027.
Understanding the segments helps in identifying the importance of different factors that aid the market growth.Download FREE Sample of this Report @ https://www.24chemicalresearch.com/download-sample/95580/global-hydrogenterminated-silicone-fluid-2021-400 Segment by Type Hydrogen Content: 0.01-0.2%Hydrogen Content: 0.01-0.3% Segment by Application Cross-linking AgentSilicone IntermediateOthers By Company Nanjing SiSiB SiliconesDongyue CroupGenesee PolymersWuhan Kemi-Works ChemicalHengyechengShanghai Chuyijia Organosilicon MaterialsJiangxi Hito Chemical Production by Region North AmericaEuropeChina Consumption by Region North AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaChina TaiwanIndonesiaThailandMalaysiaLatin AmericaMexicoBrazilArgentinaColombiaMiddle East & AfricaTurkeySaudi ArabiaUAEReasons to Purchase Our Research Report:1.
Market dynamics scenario, along with growth opportunities of the market in the years to come3.
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects4.
Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.5.
